Overview
NYC Hep B Patients for a Cure Committee Goal
Working towards a cure for HBV infection through collective action
Purpose
The Committee will provide advice to drug/medical diagnostics developers on issues related to clinical development of investigational and marketed drugs/diagnostics and their use by patients with chronic HBV infection.
The Committee may consider topics such as:
- Patient-centric clinical trial design
- Patient preference study design
- Benefit-risk determinations
- Unmet medical needs
- Patient reported outcomes or health status issues
- Other patient related topics
Proposed Next Steps
- Contact Henry if you are interested to join and serve on the Committee
- The Committee will convene its first meeting in July 2017
- Working with community partners, organize and host a citywide workshop on “Ending the Hep B Epidemic” with an official kick-off for the Committee (4Q17)
- Invite HBV drug developers to review and provide patient-centric inputs on issues related to clinical trial strategies, protocols, and designs
